BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24362016)

  • 1. Vanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicity.
    Ngwa HA; Kanthasamy A; Jin H; Anantharam V; Kanthasamy AG
    Neurotoxicology; 2014 Jul; 43():73-81. PubMed ID: 24362016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese and Vanadium Co-Exposure Induces Severe Neurotoxicity in the Olfactory System: Relevance to Metal-Induced Parkinsonism.
    Ngwa HA; Bargues-Carot A; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease.
    Afeseh Ngwa H; Kanthasamy A; Anantharam V; Song C; Witte T; Houk R; Kanthasamy AG
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):273-85. PubMed ID: 19646462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and morphological olfactory bulb modifications in mice after vanadium inhalation.
    Colín-Barenque L; Pedraza-Chaverri J; Medina-Campos O; Jimenez-Martínez R; Bizarro-Nevares P; González-Villalva A; Rojas-Lemus M; Fortoul TI
    Toxicol Pathol; 2015 Feb; 43(2):282-91. PubMed ID: 25492423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxicity following acute inhalation of aerosols generated during resistance spot weld-bonding of carbon steel.
    Sriram K; Jefferson AM; Lin GX; Afshari A; Zeidler-Erdely PC; Meighan TG; McKinney W; Jackson M; Cumpston A; Cumpston JL; Leonard HD; Frazer DG; Antonini JM
    Inhal Toxicol; 2014 Oct; 26(12):720-32. PubMed ID: 25265048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of carnosine in the olfactory bulb after vanadium inhalation in a mouse model.
    Colín-Barenque L; Bizarro-Nevares P; González Villalva A; Pedraza-Chaverri J; Medina-Campos ON; Jimenez-Martínez R; Rodríguez-Rangel DS; Reséndiz S; Fortoul TI
    Int J Exp Pathol; 2018 Aug; 99(4):180-188. PubMed ID: 30198103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's disease.
    Schintu N; Frau L; Ibba M; Garau A; Carboni E; Carta AR
    Neurotox Res; 2009 Aug; 16(2):127-39. PubMed ID: 19526289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transneuronal regulation of tyrosine hydroxylase expression in olfactory bulb of mouse and rat.
    Baker H; Kawano T; Margolis FL; Joh TH
    J Neurosci; 1983 Jan; 3(1):69-78. PubMed ID: 6130133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal administration of sodium dimethyldithiocarbamate induces motor deficits and dopaminergic dysfunction in mice.
    Mack JM; Moura TM; Lanznaster D; Bobinski F; Massari CM; Sampaio TB; Schmitz AE; Souza LF; Walz R; Tasca CI; Poli A; Doty RL; Dafre AL; Prediger RD
    Neurotoxicology; 2018 May; 66():107-120. PubMed ID: 29605442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
    Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
    Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant α-synuclein.
    Zhang S; Xiao Q; Le W
    PLoS One; 2015; 10(3):e0119928. PubMed ID: 25799501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease.
    Prediger RD; Aguiar AS; Rojas-Mayorquin AE; Figueiredo CP; Matheus FC; Ginestet L; Chevarin C; Bel ED; Mongeau R; Hamon M; Lanfumey L; Raisman-Vozari R
    Neurotox Res; 2010 Feb; 17(2):114-29. PubMed ID: 19629612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ventral glomerular deficit in Parkinson's disease revealed by whole olfactory bulb reconstruction.
    Zapiec B; Dieriks BV; Tan S; Faull RLM; Mombaerts P; Curtis MA
    Brain; 2017 Oct; 140(10):2722-2736. PubMed ID: 28969383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanadium pentoxide induces pulmonary inflammation and tumor promotion in a strain-dependent manner.
    Rondini EA; Walters DM; Bauer AK
    Part Fibre Toxicol; 2010 Apr; 7():9. PubMed ID: 20385015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
    Schintu N; Frau L; Ibba M; Caboni P; Garau A; Carboni E; Carta AR
    Eur J Neurosci; 2009 Mar; 29(5):954-63. PubMed ID: 19245367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in catechol contents in the olfactory bulb of control and unilaterally deprived rats.
    Gómez C; Briñón JG; Valero J; Recio JS; Murias AR; Curto GG; Orio L; Colado MI; Alonso JR
    Eur J Neurosci; 2007 Mar; 25(5):1517-28. PubMed ID: 17425578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsecond Regulation of Synaptically Released Dopamine by COMT in the Olfactory Bulb.
    Cockerham R; Liu S; Cachope R; Kiyokage E; Cheer JF; Shipley MT; Puche AC
    J Neurosci; 2016 Jul; 36(29):7779-85. PubMed ID: 27445153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice.
    Choi JG; Huh E; Ju IG; Kim N; Yun J; Oh MS
    J Neurol Sci; 2018 Sep; 392():77-82. PubMed ID: 30031172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
    Achat-Mendes C; Anderson KL; Itzhak Y
    Neuropsychopharmacology; 2007 Mar; 32(3):531-41. PubMed ID: 16760923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease.
    Prediger RD; Batista LC; Medeiros R; Pandolfo P; Florio JC; Takahashi RN
    Exp Neurol; 2006 Dec; 202(2):391-403. PubMed ID: 16908021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.